AU2977500A - Advanced antigen presentation platform - Google Patents

Advanced antigen presentation platform

Info

Publication number
AU2977500A
AU2977500A AU29775/00A AU2977500A AU2977500A AU 2977500 A AU2977500 A AU 2977500A AU 29775/00 A AU29775/00 A AU 29775/00A AU 2977500 A AU2977500 A AU 2977500A AU 2977500 A AU2977500 A AU 2977500A
Authority
AU
Australia
Prior art keywords
antigen presentation
presentation platform
advanced
advanced antigen
platform
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU29775/00A
Inventor
Timothy P. Coleman
Darrell L Peterson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BIOCACHE PHARMACEUTICALS LLC
Virginia Commonwealth University
Original Assignee
BIOCACHE PHARMACEUTICALS LLC
Virginia Commonwealth University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BIOCACHE PHARMACEUTICALS LLC, Virginia Commonwealth University filed Critical BIOCACHE PHARMACEUTICALS LLC
Publication of AU2977500A publication Critical patent/AU2977500A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6075—Viral proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU29775/00A 1999-02-02 2000-02-02 Advanced antigen presentation platform Abandoned AU2977500A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11852699P 1999-02-02 1999-02-02
US60118526 1999-02-02
PCT/US2000/002413 WO2000046365A1 (en) 1999-02-02 2000-02-02 Advanced antigen presentation platform

Publications (1)

Publication Number Publication Date
AU2977500A true AU2977500A (en) 2000-08-25

Family

ID=22379155

Family Applications (1)

Application Number Title Priority Date Filing Date
AU29775/00A Abandoned AU2977500A (en) 1999-02-02 2000-02-02 Advanced antigen presentation platform

Country Status (4)

Country Link
EP (1) EP1165773A4 (en)
JP (1) JP2003520568A (en)
AU (1) AU2977500A (en)
WO (1) WO2000046365A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US6406705B1 (en) 1997-03-10 2002-06-18 University Of Iowa Research Foundation Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
PT1077722E (en) 1998-05-22 2006-12-29 Coley Pharm Group Inc Methods and products for inducing mucosal immunity
OA12028A (en) * 1999-09-25 2006-04-28 Univ Iowa Res Found Immunostimulatory nucleic acids.
ATE447967T1 (en) * 2001-09-14 2009-11-15 Cytos Biotechnology Ag PACKAGING OF IMMUNO-STIMULATIVE CPG IN VIRUS-LIKE PARTICLES: PRODUCTION METHOD AND USE
CA2502015A1 (en) 2002-12-11 2004-06-24 Coley Pharmaceutical Group, Inc. 5' cpg nucleic acids and methods of use
US7320795B2 (en) 2003-07-30 2008-01-22 Vaccine Research Institute Of San Diego Rodent hepatitis B virus core proteins as vaccine platforms and methods of use thereof
US7144712B2 (en) 2003-07-30 2006-12-05 Vaccine Research Institute Of San Diego Human hepatitis B virus core proteins as vaccine platforms and methods of use thereof
CA2534060C (en) 2003-07-30 2012-06-12 Vaccine Research Institute Of San Diego Hepatitis virus core proteins as vaccine platforms and methods of use thereof
EP1973608A1 (en) 2005-12-14 2008-10-01 Cytos Biotechnology AG Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity
DK2032592T3 (en) 2006-06-12 2013-09-02 Cytos Biotechnology Ag PROCEDURES FOR PACKING OLIGONUCLEOTIDES FOR VIRUS LIKE PARTICLES OF RNA BACTERY PHAGES
EP2125854B1 (en) 2006-12-12 2016-10-26 Kuros Biosciences AG Oligonucleotides containing high concentrations of guanine monomers
CN111593138A (en) * 2019-09-20 2020-08-28 山东省农业科学院家禽研究所 Duck hepatitis B virus recombinant polymerase isothermal amplification detection method

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07252300A (en) * 1994-03-11 1995-10-03 Immuno Japan:Kk Antigen fused protein from duck hepatitis virus and human hepatitis virus and its production
RU2189254C2 (en) * 1995-06-06 2002-09-20 Америкэн Хоум Продактс Корпорэйшн Vaccines against hepatitis viruses
TR200002338T2 (en) * 1998-02-12 2002-06-21 Immune Complex Corporation Strategically regenerated hepatitis B core proteins.

Also Published As

Publication number Publication date
EP1165773A1 (en) 2002-01-02
EP1165773A4 (en) 2005-01-05
JP2003520568A (en) 2003-07-08
WO2000046365A1 (en) 2000-08-10

Similar Documents

Publication Publication Date Title
AU7912100A (en) Pharmaceutical composition comprising an antigen
AU1290001A (en) Antibodies
AU5842000A (en) Interventive-diagnostic device
EP1072453A3 (en) Refrigeration-cycle device
AU3243300A (en) Multiparticulate formulation
AU4935000A (en) Antibodies
AU1951201A (en) Peptide antigens
AU7636600A (en) Slide apparatus
AU5784300A (en) Sheet-adhesion device
AU2977500A (en) Advanced antigen presentation platform
AU6483300A (en) Device for carrying objects
AU5977700A (en) Vaccines
AU2001261025A1 (en) Tilting platform checkweighing device
AU3283500A (en) Tumor-associated antigen
AU6158700A (en) Vaccine
AU3801900A (en) Starting device
AU7788600A (en) Colon-tumour-associated antigens
AU7400700A (en) Transportation device
AU5811600A (en) Vaccine
AU7421200A (en) Device
AU6582600A (en) Access platform
AU2202801A (en) Antigen preparations
AUPQ364999A0 (en) Device
AUPQ477299A0 (en) Relocatable platform
AUPQ477399A0 (en) Presentation means

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase